Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00966667 |
Recruitment Status :
Completed
First Posted : August 27, 2009
Last Update Posted : September 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.
PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.
Condition or disease |
---|
Colorectal Cancer |
OBJECTIVES:
Primary
- To characterize patterns and identify predictors of post-treatment physical activity and dietary changes made by colorectal cancer survivors.
Secondary
- To identify the affective and cognitive effects of post-treatment physical activity and dietary changes in these patients.
- To identify these patients' preferences regarding diet and physical activity health promotion programs.
OUTLINE: This is a multicenter study.
Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.
During each survey, questionnaires are administered to assess the following areas: physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.
Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.
Study Type : | Observational |
Estimated Enrollment : | 222 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Prospective |
Official Title: | Health Behaviors Among Individuals Diagnosed With Colorectal Cancer |
Study Start Date : | November 2009 |
Actual Primary Completion Date : | August 7, 2019 |
Actual Study Completion Date : | August 7, 2019 |

Group/Cohort |
---|
cancer survivor
cancer survivor
|
- Self-efficacy for changing physical activity and dietary practices [ Time Frame: 3 yrs ]
- Outcome expectations with regard to physical activity and dietary practices [ Time Frame: 3 yrs ]
- Behavioral self-regulation of physical activity and dietary practices [ Time Frame: 3 yrs ]
- Perceived role of physical activity and dietary factors in causing colorectal cancer (CRC) and preventing recurrence (CRC illness representations) [ Time Frame: 3 yrs ]
- Perceived risk of CRC recurrence [ Time Frame: 3 yrs ]
- Cancer-related anxiety and worry about cancer recurrence (emotional representations of CRC) [ Time Frame: 3 yrs ]
- Receipt of healthcare provider recommendations to alter physical activity and diet [ Time Frame: 3 yrs ]
- Normative influences of family and friends [ Time Frame: 3 yrs ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
DISEASE CHARACTERISTICS:
-
Diagnosis of localized or regional colorectal cancer
- Stage I, II, or III disease
- Completed treatment within the past 6 weeks
- No previous diagnosis of colorectal cancer
PATIENT CHARACTERISTICS:
- English speaking
- No current evidence of neoplastic disease except for nonmelanoma skin cancer
- No evidence of severe cognitive impairment
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00966667
United States, New Jersey | |
Cooper Hospital/University Medical Center | |
Camden, New Jersey, United States, 08103 | |
JFK Medical Center in Edison | |
Edison, New Jersey, United States, 08818 | |
Centrastate Healthcare System | |
Freehold, New Jersey, United States, 07728 | |
Robert Wood Johnson University Hospital at Hamilton | |
Hamilton, New Jersey, United States, 08690 | |
Mountainside Hospital | |
Montclair, New Jersey, United States, 07042 | |
Morristown Medical Center | |
Morristown, New Jersey, United States, 07962 | |
Jersey Shore University Medical Center | |
Neptune, New Jersey, United States, 07754 | |
Rutgers Cancer Institute of New Jersey | |
New Brunswick, New Jersey, United States, 08903 | |
Saint Peters University Hospital | |
New Brunswick, New Jersey, United States, 08903 | |
University Medical Center at Princeton | |
Princeton, New Jersey, United States, 08540 | |
Robert Wood Johnson University Hospital Somerset | |
Somerville, New Jersey, United States | |
Overlook Medical Center | |
Summit, New Jersey, United States, 07901 | |
United States, Pennsylvania | |
Fox Chase Cancer Center | |
Philadelphia, Pennsylvania, United States | |
United States, Texas | |
MD Anderson Cancer Center | |
Houston, Texas, United States, 77030 |
Principal Investigator: | Elliot Coups, PhD | Rutgers Cancer Institute of New Jersey |
Responsible Party: | Rutgers, The State University of New Jersey |
ClinicalTrials.gov Identifier: | NCT00966667 |
Other Study ID Numbers: |
130901 R21CA131611 ( U.S. NIH Grant/Contract ) P30CA072720 ( U.S. NIH Grant/Contract ) K07CA133100 ( U.S. NIH Grant/Contract ) CDR0000653167 ( Other Identifier: NIH ) 0220090178 ( Other Identifier: IRB ) |
First Posted: | August 27, 2009 Key Record Dates |
Last Update Posted: | September 10, 2019 |
Last Verified: | September 2019 |
cancer survivor stage I colon cancer stage II colon cancer stage III colon cancer |
stage I rectal cancer stage II rectal cancer stage III rectal cancer |
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |